Cara Therapeutics
Why Robinhood?
You can watch CARA and buy or sell other stocks, ETFs, and their options commission-free!About CARA
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
CARA Key Statistics
Stock Snapshot
The current Cara Therapeutics(CARA) stock price is $15.96, with a market capitalization of 149.73M. The stock trades at a price-to-earnings (P/E) ratio of -1.20.
Cara Therapeutics(CARA) stock opened on 2026-05-19 at —. The price climbed to — and dipped to —.
Cara Therapeutics(CARA) shares are trading with a volume of 0, against a daily average of 45.14K.
During the past year, Cara Therapeutics(CARA) stock moved between $2.75 at its lowest and $43.65 at its peak.
During the past year, Cara Therapeutics(CARA) stock moved between $2.75 at its lowest and $43.65 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.